Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9026 - 9050 of 9148 in total
FLT201 is a recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta (β)-glucocerebrosidase variant 85 (GCasevar85)
Investigational
FLT190 is a recombinant adeno-associated viral vector serotype S3 containing DNA encoding for human alpha-galactosidase A.
Investigational
tgAAG-76 consists of a recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65.
Investigational
RBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein.
Investigational
Investigational
AGTC-401 is a recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3).
Investigational
Investigational
Maplirpacept is a recombinant fusion protein consisting of the CD47-binding domain of human signal regulatory protein alpha (SIRPa) linked to the IgG4 Fc region of human IgG.
Investigational
RAPA-201 is an autologous rapamycin-resistant T-cell therapy.
Investigational
PB-722 is a long-acting glucagon receptor agonist.
Investigational
AVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.
Investigational
Investigational
Investigational
Investigational
Investigational
VG161 is an oncolytic virus therapy under investigation for the treatment of cholangiocarcinoma.
Investigational
UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit
Investigational
PT217 is a bispecific Antibody against DLL3 and CD47
Investigational
Emerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor.
Investigational
ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47
Investigational
VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles
Investigational
Heat stable ricin vaccine is an alum-adjuvanted, heat stable recombinant subunit vaccine.
Investigational
Investigational
Recombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.
Investigational
LTI-03 is a caveolin-1 Scaffolding Domain 7-Mer
Investigational
Displaying drugs 9026 - 9050 of 9148 in total